2′-Fluoroacetophenone CAS 445-27-2 Puritas >98.0% (GC)

Description:

Nomen chemicum: 2′-Fluoroacetophenone

Synonyma: 1-(2-Fluoropheny) ethanone

CAS: 445-27-2

Puritas: >98.0% (GC)

Aspectus: hyalina ad lux Yellow Liquid

High Quality, Commercial Production

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et elit 2'-Fluoroacetophenone (CAS: 445-27-2) cum qualitate magna.CoA praebere possumus, totius orbis partus, parvas et parvas quantitates in promptu habentes.Si interesse in hoc facto, singula informationes mittas mitte nobis numerum CAS, nomen productum, quantitatem nobis.Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	2'-Fluoroacetophenone
Synonyma	o-Fluoroacetophenone;2-Fluoroacetophenone;1-(2-Fluorophenyl)ethanone;1-(2-Fluorophenyl) ethan-1-one
CAS Number	445-27-2
CATTUS Number	RF2963
Stock Status	In Stock, Productio Capacity 20 Tons per Month
Formulae hypotheticae	C8H7FO
M. Pondus	138.14
Ferveret	82.0~83.0℃/10 mmHg
Mico punctum	61°(141°F)
Solubilitas	Solubile in Acetone, Chloroforme, Dichloromethane, Ethanol, Ethyl Acetate et Methanolo.
Periculum Classis	Irritant
Stipare Group	III
HS Code*	29147090
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Hyalina lux Yellow Liquid
Puritas / Analysis Methodus	>98.0% (GC)
Densitas (20℃)	1.139~1.142
Index refractivus n20/D	1.507~1.509
1 H NMR Spectrum	Congruunt cum Structure
LCMS	Congruunt cum Structure
Aqua (auctore Karl Fischer)	<0.50%
Totalis immunditias	<2.00%
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical Medium;Vonoprazan Fumarate medium / Impurity

Sarcina & Repono:

sarcina: Fluorinated Utrem, 25kg/Drum, 200kg/Drum, vel secundum exigentiam emptoris

Repono Condition:Condite in vasis signatis in loco frigido et sicco.A luce et humore protege.Copia a validis oxidizing agentibus.

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.

Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

Applicatio:

2'-Fluoroacetophenone (CAS: 445-27-2) est medium pharmaceuticum, quod in materia inchoativa adhiberi potest ad synthesim Vonoprazan Fumarate (CAS: 1260141-27-2).Vonoprazan Fumarate (Takecab®), inventa et evoluta ab Takeda et Otsuka, ab PMDA Iaponiae mense Decembri 2014 approbata est, et curatione ulceris gastrici, duodeni ulceris et reflux esophagitis indicatur.Vonoprazan Fumarate novam mechanismum actionis quae acidum potassium-competitivum obstructores habet, quae certatim ligationem potassii ad H+, K+-ATPase (etiam sentinam protonicam notam) in ultimo gradu acidi gastrici secretionis gastrici parietalis inhibent.Vonoprazan non inhibet Na+, K+-ATPase activitatem etiam in concentionibus 500 vicibus altioribus quam valorum suorum IC50 contra gastricam H+, K+-ATPase actionem.Praeterea medicamentum a secretoriis gastrici statu non caret, dissimili PPIs.